Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oxford Health Plan (OXHP) -- Ignore unavailable to you. Want to Upgrade?

To: Stephen M. DeMoss who wrote (735)	1/9/1998 3:22:00 AM
From: Thomas Haegin	Read Replies (1) \| Respond to of 2068

Steven, I agree that mgmnt shakeup is positive. Just curious to see who they will be able to convince (for CEO and CFO) that OXHP is a worthwhile co. to join. M.Price looking at it also definitely a good sign. However, I will restrain myself at this point to load up for now. Should prices rise from here to $30 sometimes this year, I'll still show a gain (from $25) and will consider my present hesitation/missing the chance (maybe) to buy more at $17 the price to pay for being in too early in the first place. I think a comeback for OXHP is possible, just waiting a little more here. Premier, yes, talk of death is premature. My guess based on announcement dates history is that OXHP will announce EPS for 12/97 the first week of February (wk of 02/02). But I admit not to have a confirmation for this. Greetings, Tom